This report contains market size and forecasts of Glanzmann Thrombasthenia Therapeutic Drug in Global, including the following market information:
Global Glanzmann Thrombasthenia Therapeutic Drug Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Glanzmann Thrombasthenia Therapeutic Drug market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Platelet Transfusion Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Glanzmann Thrombasthenia Therapeutic Drug include Novo Nordisk, Alnylam Pharmaceuticals, Shire (Takeda), Biogen, Bioverativ (Sanofi), Bayer, CSL Behring, Grifols and Bristol-Myers Squibb and etc. In 2021, the global top five players have a share approximately % in terms of revenue.
MARKET MONITOR GLOBAL, INC (MMG) has surveyed the Glanzmann Thrombasthenia Therapeutic Drug companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Glanzmann Thrombasthenia Therapeutic Drug Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Glanzmann Thrombasthenia Therapeutic Drug Market Segment Percentages, by Type, 2021 (%)
Platelet Transfusion
Recombinant Activated Factor VII
Antifibrinolytics
Fibrin Sealants
Thrombin
Desmopressin
Global Glanzmann Thrombasthenia Therapeutic Drug Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Glanzmann Thrombasthenia Therapeutic Drug Market Segment Percentages, by Application, 2021 (%)
Hospital
Clinic
Others
Global Glanzmann Thrombasthenia Therapeutic Drug Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Glanzmann Thrombasthenia Therapeutic Drug Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Glanzmann Thrombasthenia Therapeutic Drug revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Glanzmann Thrombasthenia Therapeutic Drug revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Novo Nordisk
Alnylam Pharmaceuticals
Shire (Takeda)
Biogen
Bioverativ (Sanofi)
Bayer
CSL Behring
Grifols
Bristol-Myers Squibb
Pfizer